Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

767 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance Status.
Travers A, Jalali A, Begbie S, Semira C, Kosmider S, Ananda S, Wong R, Lee M, Shapiro J, Burge M, Yip D, Torres J, Ma B, Nott L, Dean A, Tie J, Khattak A, Lim S, Wong HL, Gibbs P. Travers A, et al. Among authors: jalali a. Clin Colorectal Cancer. 2021 Mar;20(1):e21-e34. doi: 10.1016/j.clcc.2020.08.002. Epub 2020 Aug 12. Clin Colorectal Cancer. 2021. PMID: 32919889
Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data.
Degeling K, Wong HL, Koffijberg H, Jalali A, Shapiro J, Kosmider S, Wong R, Lee B, Burge M, Tie J, Yip D, Nott L, Khattak A, Lim S, Caird S, Gibbs P, IJzerman M. Degeling K, et al. Among authors: jalali a. Pharmacoeconomics. 2020 Nov;38(11):1263-1275. doi: 10.1007/s40273-020-00951-1. Pharmacoeconomics. 2020. PMID: 32803720
Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancer.
Prasanna T, Wong R, Price T, Shapiro J, Tie J, Wong HL, Nott L, Roder D, Lee M, Kosmider S, Jalali A, Burge M, Padbury R, Maddern G, Carruthers S, Moore J, Sorich M, Karapetis CS, Gibbs P, Yip D. Prasanna T, et al. Among authors: jalali a. Curr Probl Cancer. 2021 Feb;45(1):100637. doi: 10.1016/j.currproblcancer.2020.100637. Epub 2020 Aug 14. Curr Probl Cancer. 2021. PMID: 32826083 Review.
Patient demographics and management landscape of metastatic colorectal cancer in the third-line setting: Real-world data in an australian population.
Min ST, Roohullah A, Tognela A, Jalali A, Lee M, Wong R, Shapiro J, Burge M, Yip D, Nott L, Zimet A, Lee B, Dean A, Steel S, Wong HL, Gibbs P, Lim SH. Min ST, et al. Among authors: jalali a. Asia Pac J Clin Oncol. 2022 Apr;18(2):e56-e63. doi: 10.1111/ajco.13553. Epub 2021 Apr 18. Asia Pac J Clin Oncol. 2022. PMID: 33870631
Treatment and Outcomes of Oligometastatic Colorectal Cancer Limited to Lymph Node Metastases.
Mathai VK, Aung SY, Wong V, Dunn C, Shapiro J, Jalali A, Wong R, Lee M, Tie J, Ananda S, Kosmider S, Lim SH, Caird S, Burge M, Dean A, Gibbs P, Nott L. Mathai VK, et al. Among authors: jalali a. Clin Colorectal Cancer. 2021 Dec;20(4):e233-e239. doi: 10.1016/j.clcc.2021.06.003. Epub 2021 Jun 25. Clin Colorectal Cancer. 2021. PMID: 34289941
Initial experience of TAS-102 chemotherapy in Australian patients with Chemo-refractory metastatic colorectal cancer.
Jalali A, Gard G, Banks S, Dunn C, Wong HL, Wong R, Lee M, Gately L, Loft M, Shapiro JD, Kosmider S, Tie J, Ananda S, Yeung JM, Jennens R, Lee B, McKendrick J, Lim L, Khattak A, Gibbs P. Jalali A, et al. Curr Probl Cancer. 2022 Apr;46(2):100793. doi: 10.1016/j.currproblcancer.2021.100793. Epub 2021 Sep 20. Curr Probl Cancer. 2022. PMID: 34565601
767 results